Mendota Financial Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5	Closed	-$156	–	1066
2024 Q3	$156	Buy	+5	New	+$156	﹤0.01%	729
2023 Q2	–	Sell	-1,415	Closed	-$45.7K	–	376
2023 Q1	$45.7K	Buy	+1,415	New	+$45.7K	0.05%	145